Connexions Novartis AG

NOVN

CH0012005267

Produits pharmaceutiques

Marché Fermé - Swiss Exchange 17:31:44 31/08/2026			Varia. 5j.	Varia. 1 janv.
123,26 ^CHF	-0,39%		-2,76%	+12,46%

11:32	Bourse Zurich: les indices toujours hésitants à l'approche de la mi-journée	AW
09:41	Bourse Zurich: ouverture hésitante, nouvelles tensions dans le Golfe	AW

46

Sociétés cotées

50

Entreprise privées

483

Insiders

Graphique Relationnel des Sociétés Cotées liées: Novartis AG

Relations Actives

Relations Passées

Sociétés Cotées liées: Novartis AG

STMICROELECTRONICS N.V.

Ana de Pro Gonzalo

METTLER-TOLEDO INTERNATIONAL, INC.

Ingrid Zhang

PHIBRO ANIMAL HEALTH CORPORATION

Judith Weinstein

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Nancy Andrews

MONDELEZ INTERNATIONAL, INC.

Dirk Van de Put

Brian McNamara

LEXICON PHARMACEUTICALS, INC.

Michael Exton

OBERSTDORFER BERGBAHN AG

Steffen Lang

MILESTONE PHARMACEUTICALS INC.

Joseph Papa

Guy Rousseau

AURA BIOSCIENCES, INC.

MOLECULAR PARTNERS AG

Michael Pitzner

BIONTECH SE

Susanne Antonie Schaffert

CANDEL THERAPEUTICS, INC.

AURINIA PHARMACEUTICALS INC.

JOHNSON CONTROLS INTERNATIONAL PLC

AGOMAB THERAPEUTICS NV

David Epstein

Angelika Jahreis

NRX PHARMACEUTICALS, INC.

NORDICUS PARTNERS CORPORATION

Relations Actives

Relations Passées

Graphique Relationnel des Sociétés Privées liées: Novartis AG

Relations Actives

Relations Passées

Entreprise Privées liées: Novartis AG

Novartis International AG

Pharmaceuticals: Major

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Serica Technologies, Inc.

Pharmaceuticals: Major

F. Ball

David Pyott

abrdn Life Sciences Investors

Investment Trusts/Mutual Funds

Jeffrey Bailey

Kathy Goetz

abrdn Healthcare Opportunities Fund

Investment Trusts/Mutual Funds

Jeffrey Bailey

Kathy Goetz

STADA Arzneimittel AG

Pharmaceuticals: Generic

Eric Cornut

Miguel Fernandez

Novo Holdings A/S (Denmark)

Investment Managers

Susanne Antonie Schaffert

Viviane Monges

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Jonathan Symonds

John McAdoo

The General Hospital Corp.

Hospital/Nursing Management

Mark Fishman

Mason W. Freeman

Atlas Venture Advisors, Inc.

Investment Managers

Jeffrey Hrkach

Vic Myer

Northwestern University

Other Consumer Services

Bridgette Heller

Elizabeth McNally

University of St. Gallen

Other Consumer Services

Thomas Werlen

Ruth Metzler-Arnold

American Bar Association

Miscellaneous Commercial Services

Shannon Klinger

Diane E. Sugrue

Novartis Pharmaceuticals Corp.

Pharmaceuticals: Major

University of Basel

Other Consumer Services

National Academy of Sciences

Miscellaneous Commercial Services

William J. Rutter

Charles Sawyers

Nancy Andrews

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Ann Marie Fudge

William J. Rutter

Charles Sawyers

National Academy of Medicine (United States)

Miscellaneous Commercial Services

The District of Columbia Bar

Miscellaneous Commercial Services

Shannon Klinger

Theresa Maria Stevens

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Kim Stratton

Giovanni Caforio

Patrick Horber

Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Abbie Celniker

Udit Batra

Novartis Institutes for Biomedical Research, Inc.

Miscellaneous Commercial Services

Hans Jörg Reinhardt

Harry Werner Kirsch

Novartis Pharma AG

Pharmaceuticals: Major

Harvard Medical School

Other Consumer Services

Mason W. Freeman

Nancy Andrews

Vasant Narasimhan

Waters Technologies Corp.

Medical Specialties

Udit Batra

Amol Chaubal

IMD Scholarship Foundation

Karen Hübscher

Marie-France Tschudin

SIX Swiss Exchange AG

Investment Banks/Brokers

Thomas Werlen

Andreas von Planta

Novartis Pharma KK

Pharmaceuticals: Major

Novartis Pharma BV

Swiss Bar Association

Felix R. Ehrat

Laurent Sigismondi

Zurich Bar Association

Felix R. Ehrat

Daniel Hochstrasser

The Consumer Goods Forum

Miscellaneous Commercial Services

Dirk Van de Put

Brian McNamara

Association of the European Self-Medication Industry

Brian McNamara

Udit Batra

Affidea BV

Medical/Nursing Services

Stefan Mario Meister

Frans van Houten

Galderma Holding SA

Pharmaceuticals: Major

Thomas Ebeling

Flemming Ørnskov

Vasomune Therapeutics, Inc.

Pharmaceuticals: Other

Meenu Chhabra Karson

Meenu Karson

Fore Biotherapeutics, Inc.

Pharmaceuticals: Major

Meenu Chhabra Karson

Meenu Karson

Novartis Foundation

Miscellaneous Commercial Services

Tango Therapeutics Sub, Inc.

Biotechnology

Barbara Weber

Malte Peters

Aberdeen Investments LLC

Financial Conglomerates

Jeffrey Bailey

Kathy Goetz

ImmunOs Therapeutics AG

Biotechnology

Daniel Vasella

Reinhard Ambros

Aditum Bio Fund 1 LP

Investment Managers

Joseph Jimenez

Mark Fishman

Adjuvant Capital LP

Investment Managers

Philippe Dro

Christian Mandl

Ring Therapeutics, Inc.

Pharmaceuticals: Major

David Epstein

Juan Andres

Medartis AG

Marco Gadola

Anthony Durieux-Menage

Valo Health LLC

Packaged Software

David Epstein

Shreeram Aradhye

Abata Therapeutics, Inc.

Biotechnology

Abbie Celniker

Nagesh Mahanthappa

Versanis Bio, Inc.

Biotechnology

Joseph Jimenez

Mark Fishman

Anteris Bio, Inc.

Pharmaceuticals: Major

Joseph Jimenez

Mark Fishman

Ophthalmology Foundation

Miscellaneous Commercial Services

F. Ball

David Pyott

Relations Actives

Relations Passées

Statistiques des Connexions

Actives

Inactives

Sociétés cotées

Entreprise privées

Activités des Sociétés liées

Pharmaceuticals: Major	20
Miscellaneous Commercial Services	15
Biotechnology	15
Medical Specialties	8
Other Consumer Services	4
Investment Managers	4
Industrial Machinery	3
Medical/Nursing Services	2
Food: Specialty/Candy	2
Other Transportation	2

Pays des Sociétés liées

Etats-Unis	46
Suisse	25
Pays-Bas	5
Belgique	4
Allemagne	4
France	3
Canada	3
Royaume-Uni	2
Japon	1
Danemark	1

Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA par domaine thérapeutique se répartit comme suit : - oncologie (30,9%) ; - immunologie (18,9%) ; - maladies cardio-vasculaires, rénales et métaboliques (16,4%) ; - neuroscience (11%) ; Le solde du CA (22,8%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques. A fin 2025, Novartis AG dispose de plus de 31 sites de production dans le monde. La répartition géographique du CA est la suivante : Suisse (2,6%), Europe (28,1%), Etats-Unis (42,8%), Asie-Afrique-Australasie (19,8%), Canada et Amérique latine (6,7%).

Employés

75 267

Secteur

Produits pharmaceutiques

Agenda

27/10 Publication des résultats - Q3 2026

Plus d'informations sur la société